Z160: Phase IIa started

Zalicus began a double-blind, placebo-controlled, U.S. Phase IIa trial to evaluate 375 mg oral Z160 twice daily for 6 weeks in about 140

Read the full 237 word article

How to gain access

Continue reading with a
two-week free trial.